Healthcare in the U.S.: It’s really about the money

In our third-world like health care non-system bribes and kickbacks are a normal way of doing business.  We’ve previously commented on generous gifts and salaries given providers to use a drug company’s product, this week it’s pharmacists.

The U.S. government sued Novartis Pharmaceuticals Corp. Tuesday, claiming it gave kickbacks to pharmacies to switch kidney transplant patients from competitors’ drugs to its own.

And

The government said Novartis offered one pharmacist in Los Angeles a “bonus” rebate amounting to several hundred thousand dollars to induce the pharmacist to “shoulder the burden” of switching 700 to 1,000 transplant patients to Myfortic.

Medicynical Note:  Unbelievable but true.

What’s doubly distressing is that this is not unique or unprecedented behavior by these companies which formerly called themselves “ethical.  When money is involved apparently another form of ethics emerge, i.e. greed—and it’s not good…. for patients or health care or costs.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s